Taiwan Hitachi Asia Pacific and MetaTech (AP) Inc. Agree to Establish Joint Venture Company in the Regenerative Medicine Field

Hitachi, Ltd. (TSE:6501, "Hitachi") announced today that Taiwan Hitachi Asia Pacific Co., Ltd. (President: Susy Liang), a Hitachi Group company, and MetaTech (AP) Inc., which boasts cutting-edge technologies and activities in the regenerative medicine field in Taiwan, have agreed to establish a joint venture company for the manufacture and sales of cells used in regenerative medicine, in collaboration with multiple funds and influential companies. The goal of this joint venture is to contribute to the development of regenerative medicine in Taiwan.